|
Re: A comment about market penetration
|
6
|
Resverlogix Corp.
|
Mar 20, 2017 04:25PM
|
|
Re: A comment about market penetration
|
2
|
Resverlogix Corp.
|
Mar 19, 2017 03:37PM
|
|
Re: A comment about market penetration
|
3
|
Resverlogix Corp.
|
Mar 19, 2017 01:16PM
|
|
Re: A little movie foreshadowing humor while we wait
|
2
|
Resverlogix Corp.
|
Feb 18, 2017 01:45PM
|
|
Re: NR on phase 1 Kidney Trial
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 02:04PM
|
|
Violation update
|
3
|
Resverlogix Corp.
|
Jun 24, 2016 08:07AM
|
|
Re: To those still complaining about flagging violations and removing posts.....
|
|
Resverlogix Corp.
|
Jun 23, 2016 08:05PM
|
|
Re: To those still complaining about flagging violations and removing posts.....
|
2
|
Resverlogix Corp.
|
Jun 23, 2016 05:57PM
|
|
Re: To those still complaining about flagging violations and removing posts.....
|
1
|
Resverlogix Corp.
|
Jun 23, 2016 05:29PM
|
|
Re: Dr Sweeney
|
2
|
Resverlogix Corp.
|
Jun 22, 2016 11:34AM
|
|
Re: Dr Sweeney
|
4
|
Resverlogix Corp.
|
Jun 22, 2016 11:09AM
|
|
Re: Compounds and Autoimmune
|
3
|
Resverlogix Corp.
|
Jun 21, 2016 05:23PM
|
|
Share Incentives
|
1
|
Zenith Epigenetics
|
Jun 20, 2016 12:26PM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
3
|
Zenith Epigenetics
|
Jun 16, 2016 10:21AM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
2
|
Zenith Epigenetics
|
Jun 16, 2016 08:35AM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 11:31AM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 09:16AM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 07:00PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
2
|
Resverlogix Corp.
|
Jun 13, 2016 05:16PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 04:47PM
|
